Skip to content

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01677481
Acronym
REVERE
Enrollment
1500
Registered
2012-09-03
Start date
2011-02-28
Completion date
2014-08-31
Last updated
2016-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure to Ionizing Radiation

Brief summary

The study compares radiation exposure parameters between coronary angiography procedures performed by left wrist, right wrist or groin (femoral) procedure access site

Detailed description

Patients referred for coronary angiography will be randomized to either left radial, right radial or femoral arterial access sites, and the coronary angiogram will be performed in a standard fashion, including left ventriculography. Radiation exposure parameters including Air Kerma, Dose-area product, Fluoroscopy time and Operator radiation exposure will be recorded. Operator experience as well as demographic data will be recorded.

Interventions

None listed

Sponsors

Total Cardiovascular Solutions
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* All patients undergoing diagnostic coronary angiography

Exclusion criteria

* non-availability of one or more of the three access sites History of coronary artery bypass graft surgery Need for percutaneous coronary intervention.

Design outcomes

Primary

MeasureTime frameDescription
Air Kerma1 dayThe investigators will measure Air Kerma (cumulative) at the end of the procedure of coronary angiography.

Other

MeasureTime frameDescription
Operator radiation exposure1 dayoperator radiation exposure will be measured by a personal dosimeter worn by the operator outside the lead apron on the vest pocket.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 16, 2026